Rivastigmine
- Product NDC
- 70771-1951
- 11-digit product format
- 707711951
- Labeler code
- 70771
- Product ID
- 70771-1951_eb52b342-1672-42e7-bb4c-9c8f1bce7fc3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rivastigmine
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA206318
- Marketing category
- ANDA
- Marketing start
- 2019-03-06
- Substance
- RIVASTIGMINE
- Active strength
- 13.3 mg/24h
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| PKI06M3IW0 | RIVASTIGMINE | 123441-03-2 | RIVASTIGMINE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70771-1951-7 | 70771195107 | 30 POUCH in 1 CARTON (70771-1951-7) / 24 h in 1 POUCH (70771-1951-1) | 30 pouch | 2019-03-06 | No | No | Historical |